imatinib mesylate has been researched along with Testicular Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, S; Katayama, Y; Matsui, T; Okamura, A; Wakahashi, K; Yamamoto, K | 1 |
| Kata, D; Kyrcz-Krzemień, S; Mrówka-Kata, K; Najda, J; Pajak, J; Seweryn, M | 1 |
| Beuthien-Baumann, B; Dittert, DD; Froehner, M; Schuler, U; Wirth, MP | 1 |
| Brames, MJ; Corless, CL; Einhorn, LH; Heinrich, MC; Madani, A | 1 |
| Conneally, E; Langabeer, S; Lynch, M; McCann, S; McMenamin, ME; Piccin, A | 1 |
| Handa, H; Irisawa, H; Iriuchishima, H; Karasawa, M; Matsushima, T; Murakami, H; Nojima, Y; Saitoh, T; Tsukamoto, N; Yamane, A | 1 |
| Andersson, AM; Jahnukainen, K; Nurmio, M; Paranko, J; Söder, O; Toppari, J; Zaman, F | 1 |
| Graiff, C; Mazzoleni, G; Pedersini, R; Vattemi, E | 1 |
1 review(s) available for imatinib mesylate and Testicular Neoplasms
| Article | Year |
|---|---|
Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplasms, Second Primary; Piperazines; Pyrimidines; Testicular Neoplasms; Young Adult | 2010 |
1 trial(s) available for imatinib mesylate and Testicular Neoplasms
| Article | Year |
|---|---|
Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT.
Topics: Adult; Antineoplastic Agents; Benzamides; Disease Progression; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2006 |
6 other study(ies) available for imatinib mesylate and Testicular Neoplasms
| Article | Year |
|---|---|
Possible alternative strategy for stage I imatinib-sensitive testicular seminoma; lessons from a case associated with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Benzamides; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Male; Middle Aged; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Seminoma; Testicular Neoplasms | 2010 |
Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor.
Topics: Aged; Antineoplastic Agents; Benzamides; Disease Progression; Enzyme Inhibitors; Humans; Imatinib Mesylate; Leydig Cell Tumor; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Testicular Neoplasms; Treatment Failure | 2006 |
Adenomatoid tumor of the testis in a patient on imatinib therapy for chronic myeloid leukemia.
Topics: Adenomatoid Tumor; Adult; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Testicular Neoplasms | 2006 |
Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy.
Topics: Antineoplastic Agents; Benzamides; Bone Marrow Cells; Flow Cytometry; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Philadelphia Chromosome; Piperazines; Pyrimidines; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Homologous | 2006 |
Inhibition of tyrosine kinases PDGFR and C-Kit by imatinib mesylate interferes with postnatal testicular development in the rat.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzamides; Cell Survival; Disease Models, Animal; Imatinib Mesylate; Male; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; Sertoli Cells; Spermatogenesis; Testicular Neoplasms; Testis | 2007 |
Complete response after treatment with imatinib in pretreated disseminated testicular seminoma with overexpression of c-KIT.
Topics: Adult; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Lung Neoplasms; Male; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Seminoma; Testicular Neoplasms; Tomography, Spiral Computed; Treatment Outcome; Up-Regulation | 2007 |